The DOI matches its Crossref record; 116 of the 118 references it cites were found in a registry or an index.
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Abstract
Better biomarkers are urgently needed to improve diagnosis, guide molecularly targeted therapy and monitor activity and therapeutic response across a wide spectrum of disease. Proteomics methods based on mass spectrometry hold special promise for the discovery of novel biomarkers that might form the foundation for new clinical blood tests, but to date their contribution to the diagnostic armamentarium has been disappointing. This is due in part to the lack of a coherent pipeline connecting marker discovery with well-established methods for validation. Advances in methods and technology now enable construction of a comprehensive biomarker pipeline from six essential process components: candidate discovery, qualification, verification, research assay optimization, biomarker validation and commercialization. Better understanding of the overall process of biomarker discovery and validation and of the challenges and strategies inherent in each phase should improve experimental study design, in turn increasing the efficiency of biomarker development and facilitating the delivery and deployment of novel clinical tests.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the MS detection of low-abundance proteins remains an unsolved challenge due to high dynamic range of the human proteome8–10.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [9]
In the citing paper
“Front-end protein enrichment strategies are therefore required to specifically capture and enrich low-abundance proteins from the complex biological milieu prior to MS analysis9,11.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [9]
In the citing paper
“In particular, the human blood proteome, a circulating representation of all pathophysiological processes, is immensely complex and the huge dynamic range of the blood proteome (1012) dominated by the presence of numerous highly abundant proteins, such as human serum albumin (HSA), makes the detection of low-abundance proteins extremely difficult9,10.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [9]
In the citing paper
“additional sources of uncertainty may arise from processes such as protein quantification in bottom-up proteomics (Rifai et al., 2006; Plubell et al., 2022) as measurements are made at the peptide level and isoforms can be difficult to identify (Forshed et al., 2011; Webb-Robertson et al., 2014).”
From Missing data in multi-omics integration: Recent advances through artificial intelligence (2023) · cites this paper as Rifai et al., 2006
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Beckett, A. H., Rowland, M., & TURNER, P. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,917
Practical Statistics for Medical Research.
Walter, S., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,666
Mass spectrometry-based proteomics
Aebersold, R., & Mann, M. (2003) · Nature · doi:10.1038/nature01511 · Cited by 6,955
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine
ZWEIG, M. H., & Campbell, G. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.4.561 · Cited by 6,595
Practical Statistics for Medical Research.
Bartko, J. J., & Altman, D. G. (1992) · Journal of the American Statistical Association · doi:10.2307/2290246 · Cited by 4,834
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101
Flagged first, then by citations
2 of the 118 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Entertainment Industry Foundation, Women's Cancer Research Fund Breast Cancer Biomarker Discovery Project. http://www.eifoundation.org/national/wcrf/press/article2005-10-04.html .
- International Standards Organization, I.O.F.S. Accuracy (Trueness and Precision) of Measurement Methods and Results (ISO 5725)-Part 1: General Principles and Definitions (ISO, Geneva, 1994).
Cited by
Sorted by citations
Items 701–800 of 1,000
Optimized sample preparation of endoscopic collected pancreatic fluid for SDS‐PAGE analysis
Paulo, J. A., Lee, L., Wu, B. U., Repas, K. A., Banks, P. A., Conwell, D. L., & Steen, H. (2010) · Electrophoresis · doi:10.1002/elps.200900762 · Cited by 30
Biochemical Markers of In Vivo Hepatotoxicity
Arika, W. M., & Nyamai, D. W. (2016) · Journal of Clinical Toxicology · doi:10.4172/2161-0495.1000297 · Cited by 31
Temporal profiles of plasma proteome during childhood development
Liu, C., Bramer, L., Webb‐Robertson, B., Waugh, K., Rewers, M., & Zhang, Q. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.11.016 · Cited by 29
Ahmad, R., Jang, H., Batule, B. S., & Park, H. G. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01535 · Cited by 30
Grillon, A., Westermann, B., Cantero, P., Jaulhac, B., Voordouw, M. J., Kapps, D., Collin, E., Barthel, C., Ehret‐Sabatier, L., & Boulanger, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-16749-9 · Cited by 30
Kennedy, J. J., Whiteaker, J. R., Ivey, R. G., Burian, A., Chowdhury, S., Tsai, C., Liu, T., Lin, C., Murillo, O. D., Lundeen, R. A., et al. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04382 · Cited by 31
Wei, X. L., & Li, L. (2009) · PubMed Central · Cited by 30
Recent advances in biomarker discovery in solid organ transplant by proteomics
Sigdel, T. K., & Sarwal, M. (2011) · Expert Review of Proteomics · doi:10.1586/epr.11.66 · Cited by 30
Salivary Epigenetic Biomarkers in Head and Neck Squamous Cell Carcinomas
Lim, Y., Sun, C. X., Tran, P., & Punyadeera, C. (2016) · Biomarkers in Medicine · doi:10.2217/bmm.16.2 · Cited by 32
Brault, N. D., Sundaram, H. S., Huang, C., Li, Y., Yu, Q., & Jiang, S. (2012) · Biomacromolecules · doi:10.1021/bm301335r · Cited by 29
Yen, T., Macher, B. A., McDonald, C. A., Alleyne-Chin, C., & Timpe, L. C. (2011) · Journal of Proteome Research · doi:10.1021/pr201041j · Cited by 29
Targeted Tissue Proteomic Analysis of Human Astrocytomas
Fang, X., Wang, C., Balgley, B. M., Zhao, K., Wang, W., He, F., Weil, R. J., & Lee, C. S. (2012) · Journal of Proteome Research · doi:10.1021/pr300303t · Cited by 29
Jaffuel, A., Lemoine, J., Aubert, C., Simon, R., Léonard, J., Gautier, J., Pasquier, O., & Salvador, A. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.05.068 · Cited by 29
Wei, X. L., Herbst, A. J., Ma, D., Aiken, J. M., & Li, L. (2011) · Journal of Proteome Research · doi:10.1021/pr2000495 · Cited by 29
Identification of Direct Target Engagement Biomarkers for Kinase-Targeted Therapeutics
Paweletz, C. P., Andersen, J. N., Pollock, R. M., Nagashima, K., Hayashi, M. L., Yu, S. U., Guo, H., Bobkova, E. V., Xu, Z., Northrup, A. B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026459 · Cited by 29
Sun, W., Xing, B., Guo, L., Liu, Z., Mu, J., Sun, L., Wei, H., Zhao, X., Qian, X., Jiang, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep26499 · Cited by 29
Bonnet, M., Soulat, J., Bons, J., Leger, S., de Koning, L., Carapito, C., & Picard, B. B. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.126376 · Cited by 29
Precipitation-based colorimetric multiplex immunoassay in hydrogel particles
Roh, Y. H., Lee, H. J., Kim, J. Y., Kim, H. U., Kim, S. M., & Bong, K. W. (2020) · Lab on a Chip · doi:10.1039/d0lc00325e · Cited by 29
Kim, Y., Yeo, I., Huh, I., Kim, J., Han, D., Jang, J., & Kim, Y. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3929 · Cited by 28
Bian, J., Sze, Y. H., Tse, D. Y., To, C. H., McFadden, S. A., Lam, C. S. Y., Li, K. K., & Lam, T. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094721 · Cited by 30
Frudd, K., Sivaprasad, S., Raman, R., Krishnakumar, S., Revathy, Y. R., & Turowski, P. (2021) · Acta Ophthalmologica · doi:10.1111/aos.14954 · Cited by 29
Spatial barcoding-enabled highly multiplexed immunoassay with digital microfluidics
Li, H., Liu, X., Zhu, F., Ma, D., Miao, C., Su, H., Deng, J., Ye, H., Dong, H., Bai, X., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114557 · Cited by 29
Miniaturized Microarray-Format Digital ELISA Enabled by Lithographic Protein Patterning
Stephens, A., Song, Y., McClellan, B. L., Su, S., Xu, S. H., Chen, K., Castro, M. G., Singer, B. H., & Kurabayashi, K. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115536 · Cited by 29
Discovery of nutritional biomarkers: future directions based on omics technologies
Odriozola, L., & Corrales, F. J. (2015) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2015.1038224 · Cited by 30
Basak, T., Tanwar, V. S., Bhardwaj, G., Bhardwaj, N., Ahmad, S., Garg, G., Sreenivas, V., Karthikeyan, G., Seth, S., & Sengupta, S. (2016) · Scientific Reports · doi:10.1038/srep28042 · Cited by 29
Wang, J., Tan, S., Liang, Q., Sun, S., Han, Q., & Ding, M. (2018) · Talanta · doi:10.1016/j.talanta.2018.07.059 · Cited by 29
Gao, Y., Li, S., Bao, X., Luo, C., Yang, H., Wang, J., Zhao, S., & Zheng, N. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00241 · Cited by 29
Zolla, L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.09.013 · Cited by 29
Comprehensive approaches to expanding CRISPR biosensor applications beyond nucleic acid targets
Nandi, I., Verma, J., Prasad, R., Singh, S. K., & Chandra, P. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118179 · Cited by 28
Noor, M. O., Petryayeva, E., Tavares, A. J., Uddayasankar, U., Algar, W. R., & Krull, U. J. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.08.010 · Cited by 28
Clinical proteomics and OMICS clues useful in translational medicine research
López‐Camacho, E., Madero, L., López-Pascual, J., & Latterich, M. (2012) · Proteome Science · doi:10.1186/1477-5956-10-35 · Cited by 28
Post-Genomics Nanotechnology Is Gaining Momentum: Nanoproteomics and Applications in Life Sciences
Kobeissy, F. H., Gülbakan, B., Alawieh, A. M., Karam, P., Zhang, Z., Guingab-Cagmat, J. D., Mondello, S., Tan, W., Anagli, J. Y., & Wang, K. (2014) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2013.0074 · Cited by 29
Huang, Z., Yan, G., Gao, M., & Zhang, X. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04553 · Cited by 28
Cilia, M., Howe, K. J., Fish, T. L., Smith, D., Mahoney, J. E., Tamborindeguy, C., Burd, J. D., Thannhauser, T. W., & Gray, S. M. (2011) · PROTEOMICS · doi:10.1002/pmic.201000519 · Cited by 27
Improved Ranking Functions for Protein and Modification-Site Identifications
Bern, M. W., & Goldberg, D. T. (2008) · Journal of Computational Biology · doi:10.1089/cmb.2007.0119 · Cited by 28
Dayon, L., Galindo, A. N., Cominetti, O., Corthésy, J., & Kussmann, M. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7057-5_30 · Cited by 28
Sex hormone‐binding globulin ( SHBG ) is a potential early diagnostic biomarker for gastric cancer
Cheng, C., Chang, C., Patria, Y. N., Chang, R.-T., Liu, Y., Li, F., Shih, H., & Lin, C. (2017) · Cancer Medicine · doi:10.1002/cam4.1254 · Cited by 27
Parolo, S., Marchetti, L., Lauria, M., Misselbeck, K., Scott‐Boyer, M., Caberlotto, L., & Priami, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194225 · Cited by 30
Deeke, S. A., Starr, A. E., Ning, Z., Ahmadi, S., Zhang, X., Mayne, J., Chiang, C., Singleton, R., Benchimol, E. I., Mack, D. R., et al. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0024-9 · Cited by 28
Mojgani, N., Ashique, S., Moradi, M., Bagheri, M., Garg, A., Kaushik, M., Hussain, M. S., Yasmin, S., & Ansari, M. Y. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10477-7 · Cited by 33
Brettschneider, J., Hartmann, N., Lehmensiek, V., Mogel, H., Ludolph, A. C., & Tumani, H. (2010) · Cephalalgia · doi:10.1177/0333102410375726 · Cited by 27
The discovery and validation of colorectal cancer biomarkers
Ang, C., Phung, J., & Nice, E. C. (2010) · Biomedical Chromatography · doi:10.1002/bmc.1528 · Cited by 27
Schnell, G., Bœuf, A., Westermann, B., Jaulhac, B., Lipsker, D. M., Carapito, C., Boulanger, N., & Ehret‐Sabatier, L. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.046540 · Cited by 30
Sherma, N. D., Borges, C. R., Trenchevska, O., Jarvis, J. W., Rehder, D. S., Oran, P. E., Nelson, R. W., & Nedelkov, D. (2014) · Proteome Science · doi:10.1186/s12953-014-0052-3 · Cited by 27
Depletion of Abundant Plasma Proteins by Poly(N-isopropylacrylamide-acrylic acid) Hydrogel Particles
Such-Sanmartín, G., Ventura-Espejo, E., & Jensen, O. N. (2014) · Analytical Chemistry · doi:10.1021/ac403749j · Cited by 27
Urothelial cancer proteomics provides both prognostic and functional information
de Velasco, G., Trilla‐Fuertes, L., Gámez‐Pozo, A., Urbanowicz, M., Ruiz-Ares, G., Sepúlveda-Sánchez, J. M., Prado-Vázquez, G., Arevalillo, J. M., Zapater‐Moros, A., Navarro, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15920-6 · Cited by 27
Delosière, M., Pires, J., Bernard, L., Cassar‐Malek, I., & Bonnet, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-46142-7 · Cited by 27
Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis
Duangkumpha, K., Stoll, T. M., Phetcharaburanin, J., Yongvanit, P., Thanan, R., Techasen, A., Namwat, N., Khuntikeo, N., Chamadol, N., Roytrakul, S., et al. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00242 · Cited by 27
Translational biomarkers in the era of precision medicine
Bravo-Merodio, L., Acharjee, A., Russ, D., Bisht, V., Williams, J. A., Tsaprouni, L., & Gkoutos, G. V. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.08.002 · Cited by 28
Shen, S., Wang, X., Zhu, X., Rasam, S. S., Ma, M., Huo, S., Qian, S., Zhang, M., Qu, M., Hu, C., et al. (2022) · Nature Protocols · doi:10.1038/s41596-022-00780-w · Cited by 26
In-Depth Analysis of a Plasma or Serum Proteome Using a 4D Protein Profiling Method
Tang, H., Beer, L. A., & Speicher, D. W. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-068-3_3 · Cited by 27
Protease profiling of different biofluids in type 1 diabetes mellitus
Caseiro, A., Ferreira, R. M., Quintaneiro, C., Pereira, A., Marinheiro, R., Vitorino, R. M. P., & Amado, F. M. L. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.08.027 · Cited by 27
Kim, Y.-S., Son, O. L., Lee, J. Y., Kim, S. H., Oh, S., Lee, Y. S., Kim, C., Yoo, J. S., Lee, J. H., Miyoshi, E., et al. (2008) · PROTEOMICS · doi:10.1002/pmic.200800034 · Cited by 27
Proteomics in obesity research
Barceló-Batllori, S., & Gomis, R. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800178 · Cited by 27
Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer
Park, J., Kim, S., Song, K. S., Kim, S., & Kim, S. (2015) · Genomics & Informatics · doi:10.5808/gi.2015.13.3.70 · Cited by 27
Beeton-Kempen, N., Duarte, J. D. G., Shoko, A., Serufuri, J.-M. S., John, T., Cebon, J. S., & Blackburn, J. M. (2014) · International Journal of Cancer · doi:10.1002/ijc.28832 · Cited by 27
Tang, S., Wang, J., Yang, C., Dong, L., Kong, D., & Yan, X. (2014) · Nanoscale · doi:10.1039/c4nr00806e · Cited by 27
Quantifying Antibody Binding on Protein Microarrays using Microarray Nonlinear Calibration
Yu, X., Wallstrom, G. L., Magee, D. M., Qiu, J., Mendoza, D. E. A., Wang, J., Bian, X., Graves, M. C., & LaBaer, J. (2013) · BioTechniques · doi:10.2144/000114028 · Cited by 27
Tsai, C.-H., Chen, Y., Chang, Y., Hsueh, C., Liu, C., Chang, Y., Chen, C., & Yu, J. (2018) · Oncotarget · doi:10.18632/oncotarget.24578 · Cited by 27
Discovery of Lamin B1 and Vimentin as Circulating Biomarkers for Early Hepatocellular Carcinoma
Wong, K., & Luk, J. M. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-959-4_19 · Cited by 27
Schrattenholz, A. S., & Groebe, K. (2007) · Electrophoresis · doi:10.1002/elps.200600752 · Cited by 26
Recent technical strategies to identify diagnostic biomarkers for ovarian cancer
Ye, B., Gagnon, A., & Mok, S. C. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.1.121 · Cited by 27
Development of Nucleic‐Acid‐Based Electrochemical Biosensors for Clinical Applications
Zhang, Z., Sen, P., Adhikari, B. R., Li, Y., & Soleymani, L. (2022) · Angewandte Chemie · doi:10.1002/ange.202212496 · Cited by 28
Fabián, O., Bajer, L., Drastich, P., Harant, K., Sticová, E., Ďásková, N., Módos, I., Tichánek, F., & Cahová, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119386 · Cited by 27
Biomarkers and biomarker validation: a pathologist's guide to getting it right
Paver, E. C., & Morey, A. L. (2023) · Pathology · doi:10.1016/j.pathol.2023.11.002 · Cited by 26
Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia
Pino, J. C., Posso, C., Joshi, S. K., Nestor, M. D., Moon, J., Hansen, J., Hutchinson-Bunch, C. M., Gritsenko, M., Weitz, K., Watanabe‐Smith, K., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101359 · Cited by 26
Stable Cox regression for survival analysis under distribution shifts
Fan, S., Xu, R., Dong, Q., He, Y., Chang, C., & Cui, P. (2024) · Nature Machine Intelligence · doi:10.1038/s42256-024-00932-5 · Cited by 28
Cretu, D., Diamandis, E. P., & Chandran, V. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.802408 · Cited by 26
Large-Scale SRM Screen of Urothelial Bladder Cancer Candidate Biomarkers in Urine
Duriez, E., Masselon, C., Mesmin, C., Court, M., Demeure, K., Allory, Y., Malats, N., Matondo, M., Radvanyi, F., Garin, J., et al. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00979 · Cited by 25
Gu, H., Zhao, Y., DeMichele, M., Zheng, N., Zhang, Y. J., Pillutla, R. C., & Zeng, J. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05656 · Cited by 26
Multi-Omics Approach: New Potential Key Mechanisms Implicated in Cardiorenal Syndromes
Virzì, G. M., Clementi, A., Battaglia, G. G., & Ronco, C. (2019) · Cardiorenal Medicine · doi:10.1159/000497748 · Cited by 27
El‐Daly, S. M., Morsy, S., Medhat, D., El‐Bana, M. A., Latif, Y. A., Omara, E. A. A., Awadallah, J. R., & Gamal‐Eldeen, A. M. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28925 · Cited by 26
Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis
Huizar, C. C., Raphael, I., & Forsthuber, T. G. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104219 · Cited by 26
Hou, T., Xu, N., Song, X., Yang, L., & Li, F. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.107907 · Cited by 26
Ocho, M., Togayachi, A., Iio, E., Kaji, H., Kuno, A., Sogabe, M., Korenaga, M., Gotoh, M., Tanaka, Y., Ikehara, Y., et al. (2014) · Journal of Proteome Research · doi:10.1021/pr400986t · Cited by 26
Restructuring Proteomics Through Verification
Boja, E. S., Rivers, R. C., Kinsinger, C. R., Mesri, M., Hiltke, T., Rahbar, A. M., & Rodriguez, H. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.92 · Cited by 26
Drame, P. M., Meng, Z., Bennuru, S., Herrick, J. A., Veenstra, T. D., & Nutman, T. B. (2016) · mBio · doi:10.1128/mbio.02132-15 · Cited by 26
Use of proteomics for the discovery of early markers of drug toxicity
Collins, B. C., Clarke, A., Kitteringham, N. R., Gallagher, W. M., & Pennington, S. R. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425225.3.5.689 · Cited by 26
Data Mining for Biomarker Development: A Review of Tissue Specificity Analysis
Klee, E. W. (2008) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2007.10.009 · Cited by 26
Levin, Y., Wang, L., Ingudomnukul, E., Schwarz, E., Baron‐Cohen, S., Palotás, A., & Bahn, S. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.11.007 · Cited by 26
Commercial Immunoassays in Biomarkers Studies: Researchers Beware!
Rifai, N., Watson, I. D., & Miller, W. G. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.192351 · Cited by 26
Self-citationPaulo, J. A., Lee, L., Wu, B. U., Repas, K. A., Banks, P. A., Conwell, D. L., & Steen, H. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201000018 · Cited by 25
Mass spectrometry-based membrane proteomics in cancer biomarker discovery
Mermelekas, G., & Zoidakis, J. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.917965 · Cited by 26
Plasma proteomic profiling of young and old mice reveals cadherin-13 prevents age-related bone loss
Yang, Y. R., Kabir, M. H., Park, J. H., Park, J.-I., Kang, J. S., Ju, S., Shin, Y. J., Lee, S. M., Lee, J., Kim, S., et al. (2020) · Aging · doi:10.18632/aging.103184 · Cited by 27
Bayesian methods for proteomic biomarker development
Hernández, B., Pennington, S. R., & Parnell, A. C. (2015) · EuPA Open Proteomics · doi:10.1016/j.euprot.2015.08.001 · Cited by 27
Nowatzke, W. L., Cole, T. G., & Bowsher, R. R. (2010) · Bioanalysis · doi:10.4155/bio.09.191 · Cited by 25
Systematic, evidence-based discovery of biomarkers at the NCI
Prensner, J. R., Chinnaiyan, A. M., & Srivastava, S. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9507-z · Cited by 25
Circulating pEGFR Is a Candidate Response Biomarker of Cetuximab Therapy in Colorectal Cancer
Κάτσιλα, Θ., Juliachs, M., Gregori, J., Macarulla, T. M., Villarreal, L., Bardelli, A., Torrance, C. J., Élez, E., Tabernero, J. M., & Villanueva, J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0361 · Cited by 25
Water-Soluble Dried Blood Spot in Protein Analysis: A Proof-of-Concept Study
Rosting, C., Gjelstad, A., & Halvorsen, T. G. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b01735 · Cited by 25
Qualification and Verification of Protein Biomarker Candidates
Zhao, Y., & Brasier, A. R. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41448-5_23 · Cited by 25
Fast quantitative urinary proteomic profiling workflow for biomarker discovery in kidney cancer
Lin, L., Yu, Q., Zheng, J., Cai, Z., & Tian, R. (2018) · Clinical Proteomics · doi:10.1186/s12014-018-9220-2 · Cited by 25
Creed, J. M., Maggrah, A., Reguly, B., & Harbottle, A. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0419 · Cited by 25
Electrochemical Detection of Vascular Endothelial Growth Factor by Molecularly Imprinted Polymer
Bozal‐Palabiyik, B., Lettieri, M., Uslu, B., & Marrazza, G. (2019) · Electroanalysis · doi:10.1002/elan.201900185 · Cited by 25
Overview and Introduction to Clinical Proteomics
Paik, Y., Kim, H., Lee, E.-Y., Kwon, M., & Cho, S. Y. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-117-8_1 · Cited by 25
Quantitative proteomics in cardiovascular research: Global and targeted strategies
Shen, X., Young, R. F., Canty, J. M., & Qu, J. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400014 · Cited by 25
Towards proteome standards: The use of absolute quantitation in high-throughput biomarker discovery
Chao, T., Hansmeier, N., & Halden, R. U. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.04.004 · Cited by 24
Ludwig, C., & Aebersold, R. H. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782626985-00080 · Cited by 24
Urinary peptidomics provides a noninvasive humanized readout of diabetic nephropathy in mice
Klein, J., Ramírez‐Torres, A., Ericsson, A., Huang, Y., Breuil, B., Siwy, J., Mischak, H., Peng, X.-R., Bascands, J., & Schanstra, J. P. (2016) · Kidney International · doi:10.1016/j.kint.2016.06.023 · Cited by 24
Proteomics Reveals Plasma Biomarkers for Ischemic Stroke Related to the Coagulation Cascade
Lee, J., Mun, S., Park, A., Kim, D., Lee, Y., Kim, H., Choi, H., Shin, M., Lee, S. J., Kim, J. G., et al. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01545-4 · Cited by 24
Gómez, B. B., López-Cortés, R., Nebra, J. C., Vázquez‐Estévez, S., Pérez-Fentes, D., Chantada‐Vázquez, M. D. P., Bravo, S. B., & Núñez, C. (2021) · Nanomaterials · doi:10.3390/nano11092384 · Cited by 24
Metadata
- Authors
- Rifai, N., Gillette, M. A., & Carr, S. A.
- Affiliations
- Boston Children's Hospital (US)
- Broad Institute (US)
- Corresponding author
- Carr, Steven A
- Venue
- Nature Biotechnology
- Published
- 2006-08
- Volume
- 24
- Issue
- 8
- Pages
- 971-983
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2094229819
- Cited by
- 1,867
- References
- 118
- Citations by year
- 2026: 56 · 2025: 70 · 2024: 75 · 2023: 66 · 2022: 69 · 2021: 85 · 2020: 74 · 2019: 88 · 2018: 91 · 2017: 96 · 2016: 99 · 2015: 130 · 2014: 131 · 2013: 116 · 2012: 138
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- protein biomarkers, biomarker discovery, biomarker validation, mass spectrometry-based proteomics, diagnostic biomarkers, biomarker qualification, research design
- MeSH terms
- Animals, Blood Chemical Analysis, Blood Proteins, Humans, Peptide Mapping, Sensitivity and Specificity, Mass Spectrometry, Biomarkers, Protein Array Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review